SCHEMBL21982702

SCHEMBL21982702

BC1(CO)O[C@@H](C)C(O)[C@H]1O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ FUCA1 P04066 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24974883 1.00 FUCA1 (0.32) FUCA1
SCHEMBL13674582 0.74 PYGB (0.36) —
SCHEMBL12062682 0.73 FUCA1 (0.33) FUCA1
SCHEMBL12899740 0.73 FUCA1 (0.33) FUCA1
SCHEMBL12899719 0.73 FUCA1 (0.33) FUCA1
SCHEMBL3698323 0.71 MEN1 (0.37) FUCA1
SCHEMBL11006613 0.71 MEN1 (0.37) FUCA1
SCHEMBL21367565 0.71 MEN1 (0.37) FUCA1
SCHEMBL18016617 0.71 GAA (0.35) FUCA1
SCHEMBL17702826 0.71 MEN1 (0.37) FUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10646503-B2 Isotopologues of 5-azacytidine CELGENE CORPORATION (US) 2020-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10646503-B2 Isotopologues of 5-azacytidine UNG, DCTD, DPYD FUCA1 3594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback